Furthermore, HSPB7 relative promoter methylation was significantly increased in nine cancer types by 1.07‐ to 1.37‐fold and reduced only in lung squamous cell and thyroid cancers by 0.9‐ and 0.83‐fold, respectively (P < 0.005; Fig. 3B and Table S3). The gene discussed is HSPB7; the disease is thyroid cancer.